The session discusses the implications of overdiagnosis and overtreatment in prostate cancer management, with a focus on how biopsy regimens contribute to these challenges. Furthermore, it reviews the indications, adoption, and risk assessment in active surveillance in North America and Europe, and discusses differences. The attendees will learn about the recurrence assessment in localised and advanced prostate cancer with MRI and next-generation imaging.
Chairpersons' introduction
Biopsy strategies in early detection of prostate cancer
MRI in active surveillance
Prostate cancer recurrence assessment
Interactive case-vignettes